MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
about
The Potential Dangers of Using MDMA for PsychotherapyToxicity of amphetamines: an updateNeurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancyAltered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamineLost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humansCortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users.MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study.Factors associated with initiation of ecstasy use among US adolescents: findings from a national surveyThe ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014).The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions.MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI studyMDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluidOne-year outcomes of prenatal exposure to MDMA and other recreational drugs.During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changesProcedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA usersPhysiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration.Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related ConditionsSaturday night fever in ecstasy/MDMA dance clubbers: Heightened body temperature and associated psychobiological changes.Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention.Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation.Neuropathology of substance use disorders.MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy.Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation.Recreational 3,4-methylenedioxymethamphetamine or 'ecstasy': Current perspective and future research prospects.Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.Cannabis and Ecstasy/ MDMA: empirical measures of creativity in recreational users.Patterns of ecstasy use and associated harm: results of a Brazilian online survey.MDMA can increase cortisol levels by 800% in dance clubbers.Altered visual perception in long-term ecstasy (MDMA) users.Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers.Memory and mood during the night and in the morning after repeated evening doses of MDMA.Psychoactive Substance Use among Methadone Maintenance Therapy Clients in China.Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
P2860
Q21558619-D2B8421A-40EC-49B0-8D2F-BA0A97B6D5B4Q22252794-C8D3DA9E-E3CB-4377-B194-A0CE354DC556Q24612266-DF470F52-4A3C-4ED3-BD47-C94355F2EFC9Q26858946-86471569-B489-4B03-B8D8-86E3FF6A985DQ26859367-A6F7CD44-7AA2-4DD8-9688-716BF8715932Q30478967-1B6492D7-FFF3-44FC-A238-74CF43E5CC9CQ33390410-1D72AB50-9FF9-4E63-86C2-4DEF4D8B7C1EQ33624610-0B9E16B1-5267-4883-B1A8-5A04D78767D7Q34025177-2E7C1115-DE90-4112-8662-6D10C5CBA3BDQ34359604-F1D9EC62-8AC3-4998-A382-3B371DD6A00AQ34407992-F9EF91DC-55D3-41DD-86B7-0A894557D3DCQ34786997-738749AE-F0C3-425A-8465-2A3DC88A4665Q35415158-D35B74DE-3E9C-4659-A575-2E9DA6725083Q36091083-10608F7A-B525-4E4A-BC88-3323E7FB8854Q36192900-69D9787E-37A5-4A4D-9B63-11F1887E69B3Q36587829-CE679A25-303E-4296-A22F-E5BD39CE3932Q36617655-46C65A20-DE08-48DF-A8BA-3E0E8561EA97Q36704354-6B10AAE2-842F-47BE-AB2F-0FF52555345AQ36983556-91FA4451-4905-4C0A-B3BE-D4BE66B027D8Q37146495-B80E501A-767F-46C9-8DFC-D921830B6862Q37166739-23DDE0BD-A0E7-4D15-B2DE-83F126B99E4CQ37226589-E47D9139-692A-4D66-83C7-374359CD5F63Q37323629-BFD04492-9609-48AD-BA07-FA5E5EACBEB8Q37351168-FDCCDF5E-0CC1-4DC8-B8A6-583A98D4D87CQ37416916-522F3999-90AB-4832-AD6B-6F3465E80E15Q37992113-9AB59662-60D8-46CA-AFEE-E226539035C5Q38167646-EF657703-9213-49A3-8197-BC8E6CF1B75EQ38178521-3879E792-47F4-4FDA-9E2C-44AA03325C87Q38555614-C413A75B-6BBE-49BA-872D-3E942025118FQ38665183-B9E76595-6D6E-44A3-9DC3-2AAAAED13F3DQ42708578-A1624CCD-A267-42A1-8675-CB040892B5F1Q43096892-BA32EABE-2836-487A-852A-B02E92688623Q43126641-36D29FD3-26F1-49C7-B9B7-52D29D59C1A9Q43225683-7BB5DDE2-254A-42CF-A47E-2D8686AAA600Q44261193-7B2241B6-42A2-45E1-A8FF-FF013660A31EQ45780128-729D8BBC-7FA4-45A1-AD10-5447B0051247Q46150848-CD09ADDD-5446-4801-B1EC-A04D7E5E3F9BQ46272702-E2D7A7BD-067D-4994-94BB-AD24EACA8CBCQ46357502-649E1616-3F09-442A-A3C9-2FB875AA8159Q46477520-24704D5D-8F01-4DCF-B60F-38F43B9FCC3C
P2860
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
MDMA in humans: factors which ...... e role of bioenergetic stress.
@ast
MDMA in humans: factors which ...... e role of bioenergetic stress.
@en
type
label
MDMA in humans: factors which ...... e role of bioenergetic stress.
@ast
MDMA in humans: factors which ...... e role of bioenergetic stress.
@en
prefLabel
MDMA in humans: factors which ...... e role of bioenergetic stress.
@ast
MDMA in humans: factors which ...... e role of bioenergetic stress.
@en
P2860
P356
P1476
MDMA in humans: factors which ...... e role of bioenergetic stress.
@en
P2093
Andy C Parrott
P2860
P304
P356
10.1177/0269881106063268
P407
P577
2006-03-01T00:00:00Z